Article
Activated Factor X delivered by Adeno-Associated virus significantly inhibited bleeding and alleviated hemophilia A/B arthropathy in hemophilia mice
2024-01-05
Abstract excerpt
<title>Abstract</title> <p>In hemophilia, deficient factor VIII or IX in hemophilia prevents activation of the common coagulation pathway, inhibiting conversion of FX to activated FXa required for thrombin generation. We hypothesized that delivering FXa could activate the common pathway and restore coagulation in hemophilia patients. In this study, we tried to deliver FXa by adeno-associated virus (AAV) for treat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63b9bfab-0e9e-5e23-9994-999d897a4ebd
- DOI
- 10.21203/rs.3.rs-3708399/v1
